SRI Speeds Development of Genome-Scale Models of Metabolic Networks

News   Jan 25, 2012

 
SRI Speeds Development of Genome-Scale Models of Metabolic Networks
 
 
 

RELATED ARTICLES

Using Epigenetic Signatures and Machine Learning to Improve Diagnosis

News

Unique epigenetic signatures for nine neurodevelopmental disorders have been identified, lending to a better method of diagnosis for disorders with much clinical overlap.

READ MORE

LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target Discovery

News

LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

READ MORE

Drug-like Compounds Reverse Chemotherapy Failure for 3 Aggressive Cancers

News

Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers -- ovarian, prostate and breast.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE